Trinity Biotech (TRIB) Stock Chart & Stock Price History → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free TRIB Stock Alerts $1.65 -0.01 (-0.60%) (As of 05/9/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Trinity Biotech Stock Price Performance5 Day Performance-8.45%1 Month Performance-14.51%3 Month Performance-38.63%6 Month Performance-26.55%Year-To-Date Performance-23.08%1 Year Performance-67.00% Receive TRIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… TRIB Stock Chart for Friday, May, 10, 2024 TRIB Chart by TradingView Trinity Biotech Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/09/2024$1.70$1.65-2.94%$1.78$1.6514,330 shs$12.58 million05/08/2024$1.69$1.70+0.59%$1.75$1.6624,081 shs$12.96 million05/07/2024$1.77$1.69-4.52%$1.81$1.6619,953 shs$12.88 million05/06/2024$1.80$1.77-1.79%$1.84$1.7115,470 shs$13.49 million05/03/2024$1.68$1.80+7.27%$1.80$1.6613,876 shs$13.73 million05/02/2024$1.75$1.68-4.00%$1.87$1.6826,125 shs$12.80 million Get the Latest News and Ratings for TRIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. 05/01/2024$1.82$1.75-3.85%$1.88$1.7520,031 shs$13.34 million04/30/2024$1.78$1.82+2.25%$1.82$1.786,714 shs$13.87 million04/29/2024$1.83$1.78-2.73%$1.97$1.7810,525 shs$13.56 million04/26/2024$1.83$1.83$1.84$1.814,235 shs$13.95 million04/25/2024$1.85$1.83-1.08%$1.94$1.8312,497 shs$13.95 million04/24/2024$1.85$1.85$1.91$1.8311,196 shs$14.10 million04/23/2024$1.84$1.85+0.54%$1.90$1.822,789 shs$14.10 million04/22/2024$1.81$1.84+1.92%$1.84$1.791,560 shs$14.02 million04/19/2024$1.80$1.79-0.56%$1.84$1.795,746 shs$13.64 million04/18/2024$1.83$1.80-1.64%$1.88$1.7922,890 shs$13.72 million04/17/2024$1.86$1.83-1.61%$1.83$1.823,052 shs$13.95 million04/16/2024$1.91$1.86-2.62%$1.92$1.8025,502 shs$14.17 million04/15/2024$1.86$1.91+2.69%$1.92$1.845,278 shs$14.55 million04/12/2024$1.83$1.90+3.83%$1.92$1.8513,691 shs$14.48 million04/11/2024$1.93$1.83-5.13%$1.91$1.8127,571 shs$13.95 million04/10/2024$1.93$1.93-0.05%$1.94$1.8635,873 shs$14.70 million04/09/2024$1.93$1.93$2.04$1.8874,986 shs$14.71 million04/08/2024$1.98$1.93-2.53%$2.02$1.9326,240 shs$14.71 million04/05/2024$2.00$1.98-1.02%$2.10$1.977,843 shs$15.09 million04/04/2024$2.03$2.00-1.39%$2.10$2.0013,645 shs$15.25 million04/03/2024$1.96$2.03+3.50%$2.03$1.989,738 shs$15.46 million04/02/2024$1.95$1.96+0.51%$1.97$1.948,397 shs$14.94 million04/01/2024$2.04$1.95-4.41%$2.03$1.957,885 shs$14.86 million03/29/2024$2.05$2.04-0.49%$2.04$1.9618,211 shs$15.55 million03/28/2024$1.98$2.05+3.54%$2.05$1.9618,209 shs$15.62 million03/27/2024$2.03$1.98-2.46%$2.12$1.9812,359 shs$15.09 million03/26/2024$2.11$2.03-3.79%$2.22$2.0023,335 shs$15.47 million03/25/2024$2.12$2.11-0.47%$2.21$2.1121,184 shs$16.08 million03/22/2024$2.15$2.12-1.40%$2.17$2.126,044 shs$16.15 million03/21/2024$2.20$2.15-2.27%$2.20$2.1242,710 shs$16.38 million03/20/2024$2.13$2.20+3.29%$2.25$2.123,988 shs$16.76 million03/19/2024$2.20$2.13-3.18%$2.25$2.1213,442 shs$16.23 million03/18/2024$2.24$2.20-1.79%$2.26$2.153,985 shs$16.76 million03/15/2024$2.20$2.26+2.73%$2.26$2.0912,940 shs$17.22 millionElon’s New Device is About to Shock the World (Ad)Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake.03/14/2024$2.22$2.20-0.90%$2.24$2.1213,831 shs$16.76 million03/13/2024$2.27$2.22-2.20%$2.30$2.215,965 shs$16.92 million03/12/2024$2.18$2.27+4.13%$2.29$2.1717,604 shs$17.30 million03/11/2024$2.23$2.18-2.24%$2.22$2.171,800 shs$16.61 million03/08/2024$2.22$2.23+0.45%$2.34$2.1631,344 shs$16.99 million03/07/2024$2.16$2.22+2.78%$2.35$2.1646,639 shs$16.92 million03/06/2024$2.10$2.16+2.86%$2.48$2.0814,749 shs$16.46 million03/05/2024$2.15$2.10-2.33%$2.20$2.0810,946 shs$16.01 million03/04/2024$2.15$2.15$2.20$2.1114,281 shs$16.38 million03/01/2024$2.18$2.20+0.92%$2.25$2.154,256 shs$16.76 million02/29/2024$2.20$2.18-0.91%$2.25$2.1516,363 shs$16.61 million02/28/2024$2.34$2.20-5.98%$2.35$2.2012,615 shs$16.76 million02/27/2024$2.30$2.34+1.74%$2.60$2.2626,066 shs$17.83 million02/26/2024$2.40$2.30-4.17%$2.60$2.2739,285 shs$17.53 million02/23/2024$0.45$2.40+435.95%$2.40$2.1063,090 shs$91.46 million02/22/2024$0.49$0.45-9.15%$0.49$0.44188,694 shs$17.07 million02/21/2024$2.58$0.49-80.88%$0.53$0.4742,456 shs$18.78 million02/20/2024$2.60$2.58-0.87%$2.70$2.4310,490 shs$19.65 million02/19/2024$2.60$2.60$2.70$2.498,980 shs$19.82 million02/16/2024$2.56$2.60+1.76%$2.70$2.498,977 shs$19.82 million02/15/2024$2.60$2.56-1.77%$2.77$2.5520,974 shs$19.47 million02/14/2024$2.70$2.60-3.49%$2.70$2.546,386 shs$19.83 million02/13/2024$2.80$2.70-3.75%$2.95$2.4624,288 shs$20.54 million02/12/2024$2.69$2.80+4.15%$3.10$2.7126,125 shs$21.34 million02/09/2024$2.56$2.69+4.98%$2.75$2.5510,542 shs$20.49 million02/08/2024$2.61$2.56-1.69%$2.72$2.4015,909 shs$19.52 million Related Companies: Cardio Diagnostics Stock Chart Biomerica Stock Chart OncoCyte Stock Chart MyMD Pharmaceuticals Stock Chart Navidea Biopharmaceuticals Stock Chart ImmuCell Stock Chart Aspira Women's Health Stock Chart ARCA biopharma Stock Chart Traws Pharma Stock Chart PetVivo Stock Chart Receive TRIB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TRIB) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap Profits[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsCharles Payne Demystifies OptionsUnstoppable ProsperityBiden Nomination CANCELED?The Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trinity Biotech plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.